Innoviva (INVA) Shareholder's Equity (QoQ) (2011 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Innoviva | 1.60 Bn | 992.84 Mn | 75.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.39% |
| Dec 31, 2025 | 16.13% |
| Sep 30, 2025 | 41.29% |
| Jun 30, 2025 | 10.50% |
| Mar 31, 2025 | -6.40% |
| Dec 31, 2024 | 3.38% |
| Sep 30, 2024 | 0.45% |
| Jun 30, 2024 | -5.42% |
| Mar 31, 2024 | 4.26% |
| Dec 31, 2023 | 7.56% |
| Sep 30, 2023 | 13.04% |
| Jun 30, 2023 | -1.14% |
| Mar 31, 2023 | -0.76% |
| Dec 31, 2022 | -11.78% |
| Sep 30, 2022 | 13.42% |
| Jun 30, 2022 | 2.40% |
| Mar 31, 2022 | 5.00% |
| Dec 31, 2021 | 6.94% |
| Sep 30, 2021 | 24.90% |
| Jun 30, 2021 | -43.48% |
| Mar 31, 2021 | 14.62% |
| Dec 31, 2020 | 13.64% |
| Sep 30, 2020 | 8.53% |
| Jun 30, 2020 | 21.42% |
| Mar 31, 2020 | 18.63% |
| Dec 31, 2019 | 20.56% |
| Sep 30, 2019 | 15.02% |
| Jun 30, 2019 | 23.39% |
| Mar 31, 2019 | 25.71% |
| Dec 31, 2018 | 246.89% |
| Sep 30, 2018 | 30.31% |
| Jun 30, 2018 | 26.97% |
| Mar 31, 2018 | 12.34% |
| Dec 31, 2017 | -8.86% |
| Sep 30, 2017 | 24.86% |
| Jun 30, 2017 | 11.21% |
| Mar 31, 2017 | 5.33% |
| Dec 31, 2016 | 4.04% |
| Sep 30, 2016 | -1.31% |
| Jun 30, 2016 | -0.31% |
| Mar 31, 2016 | -5.64% |
| Dec 31, 2015 | -6.08% |
| Sep 30, 2015 | -9.87% |
| Jun 30, 2015 | -13.01% |
| Mar 31, 2015 | -16.47% |
| Dec 31, 2014 | -15.64% |
| Sep 30, 2014 | -2.99% |
| Jun 30, 2014 | -171.23% |
| Mar 31, 2014 | -11.99% |
| Dec 31, 2013 | -9.37% |
| Sep 30, 2013 | 285.36% |
| Jun 30, 2013 | -6.41% |
| Mar 31, 2013 | -40.97% |
| Dec 31, 2012 | -10.54% |
| Sep 30, 2012 | -8.44% |
| Jun 30, 2012 | 2,986.87% |
| Mar 31, 2012 | 107.04% |
| Dec 31, 2011 | -47.17% |
| Sep 30, 2011 | -57.81% |